Pharming Group NV (PHARM) — Tangible Net Worth Ratio
Pharming Group NV (PHARM) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets (€0.00) from net assets (€264.64 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Pharming Group NV equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Pharming Group NV Tangible Net Worth Ratio (2005–2024)
This chart shows how Pharming Group NV's Tangible Net Worth Ratio has changed across 18 annual periods from 2005 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of €264.64 Million with intangible assets of €0.00 EUR. For live market cap and overall valuation, see Pharming Group NV (PHARM) market capitalisation.
Annual Tangible Net Worth Ratio for Pharming Group NV (2005–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Pharming Group NV from 2005 to 2024, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore PHARM capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 72.5% | €214.16 Million | €58.95 Million | €386.88 Million | ▲ +8.5 pp |
| 2023 | 64.0% | €198.05 Million | €71.27 Million | €426.34 Million | ▲ +0.7 pp |
| 2022 | 63.3% | €204.64 Million | €75.12 Million | €425.80 Million | ▲ +6.8 pp |
| 2021 | 56.5% | €192.72 Million | €83.83 Million | €396.90 Million | ▲ +7.8 pp |
| 2020 | 48.7% | €183.73 Million | €94.23 Million | €419.12 Million | ▲ +16.4 pp |
| 2019 | 32.4% | €117.26 Million | €79.32 Million | €255.63 Million | ▲ +17.3 pp |
| 2018 | 15.1% | €70.64 Million | €59.98 Million | €245.45 Million | ▲ +216.3 pp |
| 2017 | -201.2% | €22.56 Million | €67.94 Million | €199.38 Million | ▼ -94.8 pp |
| 2016 | -106.4% | €28.89 Million | €59.61 Million | €133.34 Million | ▼ -203.3 pp |
| 2015 | 97.0% | €26.06 Million | €791.55K | €63.06 Million | ▼ -0.4 pp |
| 2014 | 97.4% | €36.29 Million | €944.84K | €67.75 Million | ▲ +5.5 pp |
| 2013 | 91.9% | €6.92 Million | €559.25K | €43.37 Million | ▲ +3.4 pp |
| 2010 | 88.5% | €13.43 Million | €1.55 Million | €49.59 Million | ▲ +120.6 pp |
| 2009 | -32.1% | €19.07 Million | €25.19 Million | €80.07 Million | ▲ +11.9 pp |
| 2008 | -44.0% | €17.45 Million | €25.13 Million | €93.40 Million | ▼ -89.3 pp |
| 2007 | 45.3% | €50.58 Million | €27.67 Million | €166.72 Million | ▼ -15.0 pp |
| 2006 | 60.3% | €65.78 Million | €26.11 Million | €104.37 Million | ▼ -26.1 pp |
| 2005 | 86.4% | €34.04 Million | €4.64 Million | €40.96 Million | — |